In CRC, METTL3 catalyzes m6A modification in both the 3’ UTR of GLUT1 and the 5’/3’ UTR of HK2, stabilizing their mRNAs via an IGF2BP2/3-dependent mechanism and thereby promoting glycolysis and lactate production [86]. The gene discussed is METTL3; the disease is colorectal carcinoma.